Please assess the completion status of the following clinical trial:

Trial Title: Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet Activation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~1. Apparently healthy males and females aged 18-49 years~Exclusion Criteria:~1. History of heart disease, vascular disease, or sudden death including prior MI, coronary revascularization, congenital heart disease or history of stroke~2. Hypertension during screening: SBP\>139 or DBP\>89~3. Those who are taking medications that may be expected to blunt the physiologic response to a treadmill exercise test (e.g. beta blockers)~4. Prescription medication with known side effect of impaired thermoregulation~5. Positive pregnancy test at any time during the study~6. Resting ECG with clinical presentation suggesting coronary heart disease (e.g. pathologic Q wave)~7. Known history of gastrointestinal disease or disorder i.e. diverticulitis which creates a theoretical risk of the core temperature capsule becoming lodged in the digestive tract~8. Medications and supplements known to alter endothelial function (e.g. arginine, omega 3 fatty acids, NSAIDS, tobacco products. This exclusion may be disregarded for subjects willing to stop taking the supplement for the duration of the study~9. At the discretion of the study physician for any other medical condition or prescription medication~10. Known history of platelet dysfunction~11. Aspirin allergy or intolerance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Daily ASA, Active cool, Acute ASA (Type: EXPERIMENTAL): Two weeks of daily aspirin therapy prior to exercise, active cooling following exercise, aspirin immediately post exercise
- Daily ASA, Active cool, Acute placebo (Type: EXPERIMENTAL): Two weeks of daily aspirin therapy prior to exercise, active cooling following exercise, placebo immediately post exercise
- Daily ASA, Passive cool, Acute ASA (Type: EXPERIMENTAL): Two weeks of daily aspirin therapy prior to exercise, passive cooling following exercise, aspirin immediately post exercise
- Daily ASA, Passive cool, Acute placebo (Type: EXPERIMENTAL): Two weeks of daily aspirin therapy prior to exercise, passive cooling following exercise, placebo immediately post exercise
- Daily placebo, active cool, Acute ASA (Type: EXPERIMENTAL): Two weeks of daily placebo prior to exercise, active cooling following exercise, aspirin immediately post exercise
- Daily placebo, active cool, Acute placebo (Type: EXPERIMENTAL): Two weeks of daily placebo prior to exercise, active cooling following exercise, placebo immediately post exercise
- Daily placebo, Passive cool, Acute ASA (Type: EXPERIMENTAL): Two weeks of daily placebo prior to exercise, passive cooling following exercise, aspirin immediately post exercise
- Daily placebo, Passive cool, Acute placebo (Type: PLACEBO_COMPARATOR): Two weeks of daily placebo prior to exercise, passive cooling following exercise, placebo immediately post exercise

Based on this trial design, predict the completion outcome and termination type (if applicable).